TrialStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2012

Intensity-modulated arc therapy with cisplatin as neo-adjuvant treatment for primary irresectable cervical cancer. Toxicity, tumour response and outcome.

K Vandecasteele et al.PubMed ↗Publisher ↗

No numbers read from the abstract.